TWC
NVAX icon

TD Waterhouse Canada’s Novavax NVAX Stock Holding History

TD Waterhouse Canada’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45
Closed -$297 – 2128
2025
Q2 		$297 Hold
45
– – ﹤0.01% 1873
2025
Q1 		$270 Sell
45
-30
-40% -$248 ﹤0.01% 1832
2024
Q4 		$602 Buy
75
+15
+25% +$145 ﹤0.01% 1814
2024
Q3 		$740 Sell
60
-100
-63% -$1.29K ﹤0.01% 1728
2024
Q2 		$2.04K Buy
+160
New +$1.61K ﹤0.01% 1642
2024
Q1 		– Sell
-795
Closed -$4.09K – 1892
2023
Q4 		$4.09K Sell
795
-600
-43% -$3.67K ﹤0.01% 1407
2023
Q3 		$11.1K Hold
1,395
– – ﹤0.01% 1213
2023
Q2 		$11.4K Hold
1,395
– – ﹤0.01% 1219
2023
Q1 		$11.5K Hold
1,395
– – ﹤0.01% 1199
2022
Q4 		$15.3K Sell
1,395
-97
-7% -$1.71K ﹤0.01% 1145
2022
Q3 		$30.8K Hold
1,492
– – ﹤0.01% 1000
2022
Q2 		$92.7K Sell
1,492
-715
-32% -$37K ﹤0.01% 814
2022
Q1 		$173K Sell
2,207
-3,972
-64% -$354K ﹤0.01% 745
2021
Q4 		$873K Buy
+6,179
New +$1.06M 0.01% 508

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TD Waterhouse Canada's NVAX Position: Q3 2025 in Review

TD Waterhouse Canada sold out of Novavax (NVAX) in Q3 2025, closing a stake of 45 shares — an estimated $297 sold.

TD Waterhouse Canada first reported a position in NVAX in Q4 2021 and held it in 14 quarters. The position peaked at $873K in Q4 2021. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • TD Waterhouse Canada reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 45 Novavax shares in Q3 2025, an estimated $297.
  • TD Waterhouse Canada first reported a position in Novavax in Q4 2021 and held it in 14 quarters.
  • TD Waterhouse Canada's Novavax position peaked at $873K in Q4 2021.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on TD Waterhouse Canada's 13F filing for Q3 2025, filed 3 Nov 2025.